Feature Channels:

Immunology

Add to Favorites Subscribe Share
fbshare-Immunology
Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1554
mmc-logo.gif

Article ID: 708314

T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study finds

Mayo Clinic

Healthy white blood cells, called “T-cells,” play a crucial role in how the body fights follicular lymphoma. That's according to the results of a study led by Mayo Clinic hematologists Zhi Zhang Yang, M.D., and Stephen Ansell, M.D., Ph.D., that was published in Cell Reports. T-cells are a key part of the immune system and protect the body by fighting infections and cancer.

Released:
19-Feb-2019 1:05 PM EST
Embargo will expire:
21-Feb-2019 12:05 AM EST
Released to reporters:
19-Feb-2019 12:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Feb-2019 12:05 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

NYULangoneHealthLogo.jpg
  • Embargo expired:
    19-Feb-2019 4:00 AM EST

Article ID: 708023

Lupus Strongly Linked to Imbalances in Gut Microbiome

NYU Langone Health

The disease systemic lupus erythematosus (SLE) — marked by the attack on joints, skin, and kidneys by the body’s immune system — is linked to an abnormal mix of bacteria in the gut. This is according to a new study led by scientists at NYU School of Medicine.

Released:
13-Feb-2019 11:05 AM EST
Embargo will expire:
20-Feb-2019 2:00 PM EST
Released to reporters:
18-Feb-2019 10:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Feb-2019 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
20-Feb-2019 2:00 PM EST
Released to reporters:
18-Feb-2019 2:00 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Feb-2019 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

20190206_LaurenByers_lab_020.jpg
  • Embargo expired:
    18-Feb-2019 12:05 AM EST

Article ID: 708182

Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors

University of Texas M. D. Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair (DDR) achieved significant tumor regression in mouse models of small cell lung cancer (SCLC), suggesting a promising new approach for treating patients with this aggressive cancer.

Released:
17-Feb-2019 12:05 AM EST
  • Embargo expired:
    16-Feb-2019 5:10 PM EST

Article ID: 708091

Drug combination may become new standard treatment for advanced kidney cancer

Dana-Farber Cancer Institute

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

Released:
15-Feb-2019 2:05 PM EST
CUIMC_RGB.jpg

Article ID: 708176

Why Some Brain Tumors Respond to Immunotherapy

Columbia University Irving Medical Center

Fewer than 1 in 10 patients with glioblastoma—the most common type of brain cancer—respond to immunotherapy; a new study reveals how to detect patients who may respond.

Released:
15-Feb-2019 11:05 AM EST
MSU-Wordmark-Green-120-pxls.gif

Article ID: 708137

This Immune Cell Function Could Control Deadly Allergic Reactions

Michigan State University

Michigan State University scientists have identified a master control mechanism on mast cells, a type of immune cell, that can prevent the immune system from overreacting in times of stress, potentially limiting, or even stopping allergic reactions from happening.

Released:
14-Feb-2019 4:05 PM EST
PennMed_logo.png

Article ID: 708133

Immune Profiling: A New Opportunity for Drug Development

Perelman School of Medicine at the University of Pennsylvania

Collectively, assessing a snapshot of a person’s unique state of immune health is called immune profiling, which can entail identifying immune-cell-associated genes and proteins, as well as the cell types themselves.

Released:
14-Feb-2019 3:05 PM EST

Showing results

110 of 1554

Chat now!